Safety, Efficacy, and Drug Survival of the Infliximab Biosimilar CT-P13 in Japanese Patients With Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis
J Dermatol 2022 Jul 07;[EPub Ahead of Print], A Morita, K Nishikawa, F Yamada, K Yamanaka, H Nakajima, M OhtsukiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.